{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:49:26Z","timestamp":1790830166595,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001167","name":"Larry L. Hillblom Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001167","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG083424"],"award-info":[{"award-number":["AG083424"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA016086"],"award-info":[{"award-number":["CA016086"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006808","name":"University of North Carolina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004896","name":"Eisai Incorporated","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004896","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007625","name":"Cure Alzheimer's Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jbc.2025.108356","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T18:56:57Z","timestamp":1740509817000},"page":"108356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A high-throughput assay platform to discover small molecule activators of the phospholipase PLC-\u03b32 to treat Alzheimer's disease"],"prefix":"10.1016","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4898-8663","authenticated-orcid":false,"given":"Adam J.","family":"Carr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Hajicek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6400-544X","authenticated-orcid":false,"given":"Andy P.","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padam P.","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Brian","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Wyss-Coray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth H.","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1127-8310","authenticated-orcid":false,"given":"John","family":"Sondek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9808-5038","authenticated-orcid":false,"given":"Qisheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2025.108356_bib1","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease. Reply","volume":"388","author":"van Dyck","year":"2023","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jbc.2025.108356_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jbc.2025.108356_bib3","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s40120-023-00473-w","article-title":"A\u00a0path to improved Alzheimer's care: simulating long-term health outcomes of lecanemab in early Alzheimer's disease from the CLARITY AD trial","volume":"12","author":"Tahami Monfared","year":"2023","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.jbc.2025.108356_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1169499","article-title":"Safety and efficacy of lecanemab for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials","volume":"15","author":"Qiao","year":"2023","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.jbc.2025.108356_bib5","doi-asserted-by":"crossref","first-page":"943","DOI":"10.17219\/acem\/171379","article-title":"Lecanemab (Leqembi) is not the right drug for patients with Alzheimer's disease","volume":"32","author":"Kurkinen","year":"2023","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.jbc.2025.108356_bib6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s40265-023-01858-9","article-title":"Anti-amyloid monoclonal antibodies are transformative treatments that redefine Alzheimer's disease therapeutics","volume":"83","author":"Cummings","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.jbc.2025.108356_bib7","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/ng.3916","article-title":"Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease","volume":"49","author":"Sims","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbc.2025.108356_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00401-019-02026-8","article-title":"A\u00a0nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity","volume":"138","author":"van der Lee","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jbc.2025.108356_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13073-022-01022-0","article-title":"PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer's disease","volume":"14","author":"Tsai","year":"2022","journal-title":"Genome Med."},{"key":"10.1016\/j.jbc.2025.108356_bib10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13024-021-00436-5","article-title":"TREM2\/PLC\u03b32 signalling in immune cells: function, structural insight, and potential therapeutic modulation","volume":"16","author":"Magno","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.jbc.2025.108356_bib11","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41593-020-0650-6","article-title":"Alzheimer's-associated PLC\u03b32 is a signaling node required for both TREM2 function and the inflammatory response in human microglia","volume":"23","author":"Andreone","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jbc.2025.108356_bib12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-94-007-3012-0_3","article-title":"The phospholipase C isozymes and their regulation","volume":"58","author":"Gresset","year":"2012","journal-title":"Subcell Biochem."},{"key":"10.1016\/j.jbc.2025.108356_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1074-7613(00)00005-4","article-title":"Phospholipase C-\u03b32 is essential in the functions of B cell and several Fc receptors","volume":"13","author":"Wang","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.jbc.2025.108356_bib14","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1086\/342259","article-title":"Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype","volume":"71","author":"Paloneva","year":"2002","journal-title":"Am. J. Hum. Genet"},{"key":"10.1016\/j.jbc.2025.108356_bib15","doi-asserted-by":"crossref","first-page":"35836","DOI":"10.1074\/jbc.M110.166512","article-title":"Mechanism of phosphorylation-induced activation of phospholipase C-\u03b3 isozymes","volume":"285","author":"Gresset","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2025.108356_bib16","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.51700","article-title":"Structural basis for the activation of PLC-\u03b3 isozymes by phosphorylation and cancer-associated mutations","volume":"8","author":"Hajicek","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.jbc.2025.108356_bib17","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020105603","article-title":"PIP2 depletion and altered endocytosis caused by expression of Alzheimer's disease-protective variant PLC\u03b32 R522","volume":"40","author":"Maguire","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2025.108356_bib18","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.immuni.2023.08.008","article-title":"Genetic variants of phospholipase C-\u03b32 alter the phenotype and function of microglia and confer differential risk for Alzheimer's disease","volume":"56","author":"Tsai","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.jbc.2025.108356_bib19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13195-019-0469-0","article-title":"Alzheimer's disease phospholipase C-\u03b32 (PLCG2) protective variant is a functional hypermorph","volume":"11","author":"Magno","year":"2019","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.jbc.2025.108356_bib20","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1124\/mol.63.5.1043","article-title":"Identification of a compound that directly stimulates phospholipase C activity","volume":"63","author":"Bae","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jbc.2025.108356_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/sj.bjp.0705911","article-title":"Phospholipase C activator m-3M3FBS affects Ca2+ homeostasis independently of phospholipase C activation","volume":"143","author":"Krjukova","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jbc.2025.108356_bib22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejphar.2009.11.029","article-title":"Phospholipase C-independent effects of 3M3FBS in murine colon","volume":"628","author":"Dwyer","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jbc.2025.108356_bib23","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.77809","article-title":"Dynamics of allosteric regulation of the phospholipase C-\u03b3 isozymes upon recruitment to membranes","volume":"11","author":"Siraliev-Perez","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.jbc.2025.108356_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adn6037","article-title":"The crystal and cryo-EM structures of PLC\u03b32 reveal dynamic interdomain recognitions in autoinhibition","volume":"10","author":"Shin","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jbc.2025.108356_bib25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1021\/cb100308n","article-title":"A\u00a0fluorogenic, small molecule reporter for mammalian phospholipase C isozymes","volume":"6","author":"Huang","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jbc.2025.108356_bib26","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1074\/jbc.M112.422501","article-title":"Small molecule inhibitors of phospholipase C from a novel high-throughput screen","volume":"288","author":"Huang","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2025.108356_bib27","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1074\/jbc.RA117.000926","article-title":"A\u00a0membrane-associated, fluorogenic reporter for mammalian phospholipase C isozymes","volume":"293","author":"Huang","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2025.108356_bib28","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1021\/acs.biochem.0c00511","article-title":"A\u00a0high-throughput assay to identify allosteric inhibitors of the PLC-\u03b3 isozymes operating at membranes","volume":"59","author":"Huang","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2025.108356_bib29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13024-020-00402-7","article-title":"The Alzheimer's disease-associated protective PLC-\u03b32-P522R variant promotes immune functions","volume":"15","author":"Takalo","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.jbc.2025.108356_bib30","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/alz.12577","article-title":"The P522R protective variant of PLCG2 promotes the expression of antigen presentation genes by human microglia in an Alzheimer's disease mouse model","volume":"18","author":"Claes","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jbc.2025.108356_bib31","doi-asserted-by":"crossref","first-page":"12407","DOI":"10.1074\/jbc.M110.191783","article-title":"Direct activation of human phospholipase C by its well known inhibitor U73122","volume":"286","author":"Klein","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2025.108356_bib32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A\u00a0simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J.\u00a0Biomol. Screen"},{"key":"10.1016\/j.jbc.2025.108356_bib33","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1177\/2472555218768497","article-title":"Nuisance compounds, PAINS filters, and dark chemical matter in the GSK HTS collection","volume":"23","author":"Chakravorty","year":"2018","journal-title":"SLAS Discov."},{"key":"10.1016\/j.jbc.2025.108356_bib34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.14573\/altex.2009.2.83","article-title":"The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation","volume":"26","author":"Henn","year":"2009","journal-title":"ALTEX"},{"key":"10.1016\/j.jbc.2025.108356_bib35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0165-5728(90)90073-V","article-title":"Immortalization of murine microglial cells by a v-raf\/v-myc carrying retrovirus","volume":"27","author":"Blasi","year":"1990","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jbc.2025.108356_bib36","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ab.2006.08.002","article-title":"D-myo-inositol 1-phosphate as a surrogate of D-myo-inositol 1,4,5-tris phosphate to monitor G protein-coupled receptor activation","volume":"358","author":"Trinquet","year":"2006","journal-title":"Anal Biochem."},{"key":"10.1016\/j.jbc.2025.108356_bib37","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.slasd.2023.03.003","article-title":"A\u00a0novel fluorogenic reporter substrate for 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 (PLC\u03b32): application to high-throughput screening for activators to treat Alzheimer's disease","volume":"28","author":"Visvanathan","year":"2023","journal-title":"SLAS Discov."},{"key":"10.1016\/j.jbc.2025.108356_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0299541","article-title":"A\u00a0novel micellular fluorogenic substrate for quantitating the activity of 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma (PLC\u03b3) enzymes","volume":"19","author":"Visvanathan","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2025.108356_bib39","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJMoa2114110","article-title":"Mechanisms of resistance to noncovalent bruton's tyrosine kinase inhibitors","volume":"386","author":"Wang","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jbc.2025.108356_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100905","article-title":"The role of PLC\u03b32 in immunological disorders, cancer, and neurodegeneration","volume":"297","author":"Jackson","year":"2021","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2025.108356_bib41","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1002\/art.30280","article-title":"A\u00a0novel N-ethyl-N-nitrosourea-induced mutation in phospholipase C\u03b32 causes inflammatory arthritis, metabolic defects, and male infertility in\u00a0vitro in a murine model","volume":"63","author":"Abe","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbc.2025.108356_bib42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41398-019-0394-9","article-title":"Transethnic meta-analysis of rare coding variants in PLCG2, ABI3, and TREM2 supports their general contribution to Alzheimer's disease","volume":"9","author":"Dalmasso","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jbc.2025.108356_bib43","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1365-2125.2011.04138.x","article-title":"Unexpected frequent hepatotoxicity of a prescription drug, flupirtine, marketed for about 30 years","volume":"73","author":"Michel","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jbc.2025.108356_bib44","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-1-0716-1142-5_17","article-title":"Fluorogenic XY-69 in lipid vesicles for measuring activity of phospholipase C isozymes","volume":"2251","author":"Carr","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jbc.2025.108356_bib45","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-1-4939-2272-7_12","article-title":"Site-specific biotinylation of purified proteins using BirA","volume":"1266","author":"Fairhead","year":"2015","journal-title":"Methods Mol. Biol."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825002054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825002054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:58:09Z","timestamp":1777409889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925825002054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0021925825002054"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2025.108356","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A high-throughput assay platform to discover small molecule activators of the phospholipase PLC-\u03b32 to treat Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2025.108356","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"108356"}}